<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[GENMAB: 139 studier med Daratumumab]]></title><description><![CDATA[<p dir="auto">Lige nu er der 139 igangværende studier med Daratumumab i flere indikationer. Se den imponerende liste på link:</p>
<p dir="auto"><a href="https://www.clinicaltrials.gov/ct2/results?cond=&amp;term=Darzalex&amp;cntry=&amp;state=&amp;city=&amp;dist=" rel="nofollow ugc">https://www.clinicaltrials.gov/ct2/results?cond=&amp;term=Darzalex&amp;cntry=&amp;state=&amp;city=&amp;dist=</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/440224/genmab-139-studier-med-daratumumab</link><generator>RSS for Node</generator><lastBuildDate>Wed, 15 Jul 2026 10:17:44 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/440224.rss" rel="self" type="application/rss+xml"/><pubDate>Sat, 14 Sep 2019 08:40:06 GMT</pubDate><ttl>60</ttl></channel></rss>